Melatonin improves methamphetamine-induced blood brain barrier impairment through NADPH oxidase-2 in primary rat brain microvascular endothelium cells

Brain Research

Volumn 1646, Issue , 2016, Pages 393-401

  Jumnongprakhon, Pichaya ^a   Govitrapong, Piyarat ^b,c   Tocharus, Chainarong ^a   Tocharus, Jiraporn ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Mahidol University   (Thailand)

Author keywords

Blood brain barrier; Melatonin; Methamphetamine; Nf b; Nrf2

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; GELATINASE B; GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; METHAMPHETAMINE; NITRIC OXIDE; QUINONE OXIDOREDUCTASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROVASCULAR ENDOTHELIAL CELL; ENDOTHELIUM CELL; INTRACELLULAR SIGNALING; NEUROPROTECTION; NITRATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 84976612023     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.06.014     Document Type: Article

References (73)

1. P.M. Abdul-Muneer, and et al. Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction Mol. Neurodegener. 6 2011 1750 1756
2. D. Acuña-Castroviejo, and et al. Extrapineal melatonin: sources, regulation, and potential functions Cell Mol. Life Sci. 71 2014 2997 3025
3. W.A. Banks, and M.A. Ericson The blood-brain barrier and immune function and dysfunction Neurobiol. Dis. 37 2010 26 32
4. S. Cahill-Smith, and J.M. Li Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2 J. Clin. Pharmacol. 78 2014 441 453
5. B. Chen, and et al. The role of Nrf2 in oxidative stress-induced endothelial injuries J. Endocrinol. 225 2015 83 99
6. H.Y. Chen, and et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice J. Pineal Res. 41 2006 175 182
7. M.C. Cheng, S.H. Hsu, and C.H. Chen Chronic methamphetamine treatment reduces synaptic plasticity genes expression and changes in their DNA methylation status in the mice brain Brain Res. 15 2015 765 769
8. C.M. Chern, and et al. Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice Free Radic. Biol. Med. 52 2012 1634 1647
9. V. Coelho-Santos, and et al. The TNF-alpha/NF-kappa B signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction J. Cereb. Blood Flow Metab. 35 2015 1260 1271
10. A. Csiszar, and et al. Inflammation and endothelial dysfunction during aging: role of NF-kappaB J. Appl. Physiol. 105 2009 1333 1341
11. A. ElAli, and et al. Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication Stroke 43 2012 1647 1653
12. S. Fernandes, and et al. Acetyl-L-carnitine prevents methamphetamine-induced structural damage on endothelial cells via ILK-related MMP-9 activity Mol. Neurobiol. 25 2014 465 477
13. S. Fernandes, S. Salta, and T. Summavielle Methamphetamine promotes alpha-tubulin deacetylation in endothelial cells: the protective role of acetyl-l-carnitine Toxicol. Lett. 234 2015 131 138
14. D. Fisehr, K. Gamieldien, and P.S. Mafunda Methamphetamine is not toxic but disrupts the cell cycle of blood-brain barrier endothelial cells Neurotox. Res. 28 2015 8 17
15. G. Flora, and et al. Methamphetamine potentiates HIV-1 tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain Exp. Neurol. 1 2003 60 70
16. J.J. García, and et al. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review J. Pineal Res. 56 2014 225 237
17. S. Garrido-Urbani, V. Jaquet, and B.A. Imhof ROS and NADPH oxidase: key regulators of tumor vascularisation Med. Sci. 30 2014 415 421
18. G. Gloire, S. Legrand-Poels, and J. Piette NF-kappaB activation by reactive oxygen species: fifteen years later Biochem. Pharmacol. 72 2006 1493 1505
19. N. Granado, and et al. Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum Glia 59 2011 1850 1863
20. S.P. Gray, and K.A. Jandeliet-Dahm The role of NADPH Oxidase in vascular disease - hypertension, atherosclerosis & stroke Curr. Pharm. Des. 26 2015 510 521
21. Y. Huang, and et al. The complexity of the Nrf2 pathway: beyond the antioxidant response J. Nutr. Biochem. 15 2015 179 185
22. K. Husain, and et al. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis World J. Biol. Chem. 6 2015 209 217
23. P. Jumnongprakhon, and et al. Protective effect of melatonin on methamphetamine-induced apoptosis in glioma cell line Neurotox. Res. 25 2014 286 294
24. P. Jumnongprakhon, and et al. Melatonin protects methamphetamine-induced neuroinflammation through NF-kappa B and Nrf2 pathways in glioma cell line Neurochem. Res. 40 2015 1448 1456
25. T. Kawai, and S. Akira Signaling to NF-kappa B by toll-like receptors Trend Mol. Med. 13 2007 460 469
26. T.W. Kensler, N. Wakabayashi, and S. Biswal Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. Toxicol. 47 2007 89 116
27. K. Kothur, and et al. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review Cytokine 15 2015 72 77
28. B. Lacoste, and et al. Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain J. Pineal Res. 58 2015 397 417
29. W. Li, and et al. Activation of Nrf2-antioxidant signaling attenuates NF kappa B-inflammatory response and elicits apoptosis Biochem. Pharmacol. 76 2008 1485 1489
30. Y. Liu, and et al. A simple method for isolating and culturing the rat brain microvascular endothelial cells Microvasc. Res. 90 2013 199 205
31. J.M. Loftis, and A. Janowsky Neuroimmune basis of methamphetamine toxicity Int. Rev. Neurobiol. 118 2014 165 197
32. J. Ma, and et al. Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the kappa opioid receptor Cell Death Dis. 5 2014 e1099
33. S.D. Mahajan, and et al. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse Brain Res. 1203 2008 133 148
34. E. Maloney, and et al. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation Arterioscler. Thromb. Vasc. Biol. 29 2009 1370 1375
35. L.C. Manchester, and et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable J. Pineal Res. 59 2015 403 419
36. K.D. Mccarthy, and J. De Vellis Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J. Cell Biol. 85 1980 890 902
37. I. Miyazaki, and et al. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity Glia 59 2011 435 451
38. X.K. Nguyen, and et al. Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene J. Pineal Res. 58 2015 86 106
39. N.A. Northrop, and B.K. Yamamoto Methamphetamine effects on blood-brain barrier structure and function Front. Neurosci. 9 2015 69 72
40. E. O'Shea, and et al. Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by mdma and methamphetamine Neuropharmacology 14 2014 79 83
41. W.O. Osburn, and T.W. Kensler Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults Mutat. Res. 659 2008 31 39
42. A.M. Pacchioni, and et al. Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity Brain Res. 1 2007 26 35
43. W.J. Panenka, and et al. Methamphetamine uses: a comprehensive review of molecular, preclinical and clinical finding Drug Alcohol Depend. 129 2013 167 179
44. A. Parameyong, P. Govitrapong, and B. Chetsawang Melatonin attenuates the mitochondrial translocation of mitochondrial fission proteins and Bax, cytosolic calcium overload and cell death in methamphetamine-induced toxicity in neuroblastoma SH-SY5Y cells Mitochondrion 24 2015 1 8
45. N.U. Parikh, and et al. Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: neuroprotective role in maintaining blood brain barrier integrity Brain Res. 1624 2015 175 187
46. M. Park, and et al. Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complex-regulated actin rearrangement J. Biol. Chem. 288 2013 33324 33334
47. M. Park, B. Hennig, and M. Toborek Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae J. Cell Mol. Med. 16 2012 362 375
48. K. Perpoonpattana, and P. Govitrapong The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines Neurotox. Res. 23 2013 189 199
49. D. Pinkaew, and et al. Association of neuroprotective effect of di-O-demethylcurcumin on abeta-induced neurotoxicity with suppression of NF-kappaB and activation of Nrf2 Neurotox. Res. 26 2015 358 365
50. S.R. Radfar, and R.A. Rawson Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts Addict. Health 6 2014 146 154
51. S.H. Ramirez, and et al. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells J. Cereb. Blood Flow Metab. 29 2009 1933 1945
52. A. Ramkissoon, and P.G. Wells Developmental role of nuclear factor E2-related factor 2 in mitigating methamphetamine fetal toxicity and postnatal neurodevelopmental deficits Free Radic. Biol. Med. 65 2013 620 631
53. A. Ramkissoon, and P.G. Wells Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2 Free Radic. Biol. Med. 89 2015 358 368
54. R.J. Reiter, L.C. Manchester, and D.X. Tan Neurotoxins: free radical mechanisms and melatonin protection Curr. Neuropharmacol. 8 2010 194 210
55. H. Rosas-Hernandez, and et al. Prolactin protects against the methamphetamine-induced cerebral vascular toxicity Curr. Neurovasc. Res. 10 2013 346 355
56. T. Saito, and et al. Importance of endothelial NF-kappaB signalling in vascular remodelling and aortic aneurysm formation Cardiovasc. Res. 97 2013 106 114
57. A. Shah, and et al. Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes J. Neuroinflamm. 9 2012 52 60
58. S.D. Skaper, L. Facci, and P. Giusti Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review Neurol. Disord. Drug Targets 13 2014 1654 1666
59. D. Sun, and et al. Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalIc dopaminergic neurons Biofactors 4 2015 252 260
60. G.P. Sykiotis, and et al. The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation Curr. Opin. Clin. Nutr. Metab. Care 14 2011 41 48
61. S.B. Taylor, C.R. Levis, and M.F. Olive The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans Subst. Abuse Rehabil. 4 2013 29 43
62. J. Tocharus, and et al. Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines J. Pineal Res. 48 2010 347 352
63. A. Urrutia, and et al. A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine Neurobiol. Dis. 50 2013 49 58
64. Q. Wang, and et al. Molecular pathology of brain matrix metalloproteases, claudin5, and aquaporins in forensic autopsy cases with special regard to methamphetamine intoxication Int. J. Leg. Med. 128 2014 469 474
65. Z. Wang, and et al. Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway J. Pineal. Res. 55 2014 399 408
66. N. Wijayanti, and et al. Role of NF-kappaB and p38 MAP kinase signaling pathways in the lipopolysaccharide-dependent activation of heme oxygenase-1 gene expression Antioxid. Redox Signal. 6 2004 802 810
67. E.S. Wires, and et al. Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells J. Neurovirol. 5 2012 400 410
68. X. Xiao, and et al. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways Exp. Cell Res. 336 2015 58 65
69. S. Yu, and et al. Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology Behav. Neurol. 15 2015 103 109
70. F. Yuan, and et al. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation J. Neurochem. 136 2015 581 593.59
71. B. Zhang, and et al. Alpha 7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factors BMC Infect. Dis. 15 2015 35 42
72. H. Zhang, and et al. Role of TNF-alpha in vascular dysfunction Clin. Sci. 116 2009 219 230
73. L. Zhao, and et al. Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling J. Pineal Res. 59 2015 230 239